Nothing brings out the passionate debate like the controversy of PSA. It is well-known that there is no consensus evidence showing a mortality benefit to obtaining a screening PSA. An upcoming trial is supposed to more definitively answer the question, but recruiting patients may be difficult:
Many are awaiting the results of a multiyear trial by the National Cancer Institute and other medical organizations called the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. PSA experts at the conference pointed out, however, that enrolling patients in a randomized controlled trial where some patients forego screening will be difficult because of the widespread acceptance of PSA screening.
Related posts:
- Should I get a PSA test for prostate cancer? A new study shows that screening for prostate cancer doesn’t necessarily save lives
- Confusion surrounding prostate cancer screening
- Prostate cancer screening in men over 75
- Who’s not happy with the new prostate cancer screening recommendations?
- Prostate cancer screening in blacks, and the lack of balanced information
- Not all doctors discuss the risks and benefits of prostate cancer screening to patients
- Will patients accept the limitations of prostate cancer screening?
KevinMD.com on Facebook
Comments on this entry are closed.